nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A candidate Ross River virus vaccine: preclinical evaluation
|
Aaskov, John |
|
1997 |
15 |
12-13 |
p. 1396-1404 9 p. |
artikel |
2 |
Addition of the MSA1 signal and anchor sequences to the malaria merozoite surface antigen 1 C-terminal region enhances immunogenicity when expressed by recombinant vaccinia virus
|
Yang, Shutong |
|
1997 |
15 |
12-13 |
p. 1303-1313 11 p. |
artikel |
3 |
A nasal whole-cell pertussis vaccine can induce strong systemic and mucosal antibody responses which are not enhanced by cholera toxin
|
Herland Berstad, Aud Katrine |
|
1997 |
15 |
12-13 |
p. 1473-1478 6 p. |
artikel |
4 |
An influenza A live attenuated reassortant virus possessing three temperature-sensitive mutations in the PB2 polymerase gene rapidly loses temperature sensitivity following replication in hamsters
|
Murphy, Brian R. |
|
1997 |
15 |
12-13 |
p. 1372-1378 7 p. |
artikel |
5 |
Annually repeated influenza vaccination improves humoral responses to several influenza virus strains in healthy elderly
|
de Bruijn, Iris A. |
|
1997 |
15 |
12-13 |
p. 1323-1329 7 p. |
artikel |
6 |
A systematic method for evaluating the potential viability of local vaccine producers
|
Milstien, J. |
|
1997 |
15 |
12-13 |
p. 1358-1363 6 p. |
artikel |
7 |
Commensal bacteria as vectors for mucosal vaccines against sexually transmitted diseases: vaginal colonization with recombinant streptococci induces local and systemic antibodies in mice
|
Medaglini, Donata |
|
1997 |
15 |
12-13 |
p. 1330-1337 8 p. |
artikel |
8 |
Critical value of prevalence for vaccination programmes. The case of hepatitis A vaccination in Spain
|
Plans Rubió, Pedro |
|
1997 |
15 |
12-13 |
p. 1445-1450 6 p. |
artikel |
9 |
Delivering active peptides and antigens in non-pathogenic bacteria; recombinant vaccine construction by antigen or recombinant protein expression in Listeria monocytogenes or Lactococcus lactis.
|
|
|
1997 |
15 |
12-13 |
p. 1487-1488 2 p. |
artikel |
10 |
Diagnosing Trypanosoma cruzi infection by detecting antibodies specific for new antigens; antigen cloning and expression for use as in Chagas disease diagnosis or as a recombinant vaccine
|
|
|
1997 |
15 |
12-13 |
p. 1487- 1 p. |
artikel |
11 |
Differences in the immunogenicity of native and formalinized cross reacting material (CRM197) of diphtheria toxin in mice and guinea pigs and their implications on the development and control of diphtheria vaccine based on CRMs
|
Gupta, Rajesh K. |
|
1997 |
15 |
12-13 |
p. 1341-1343 3 p. |
artikel |
12 |
Dodecahedral adenoviral complex containing penton bases and optionally fibers; adenovirus vector construction using a baculo virus in Trichoplusia ni or Spodoptera frugiperda insect cell culture, for use as a recombinant vaccine or in gene therapy
|
|
|
1997 |
15 |
12-13 |
p. 1487- 1 p. |
artikel |
13 |
Enhanced antibody response in cattle against Leptospira hardjo by intradermal vaccination
|
Samina, Itzchak |
|
1997 |
15 |
12-13 |
p. 1434-1436 3 p. |
artikel |
14 |
Evaluation of bivalent live attenuated influenza A vaccines in children 2 months to 3 years of age: safety, immunogenicity and dose-response
|
Gruber, William C. |
|
1997 |
15 |
12-13 |
p. 1379-1384 6 p. |
artikel |
15 |
Expression of the serine rich Entamoeba histolytica protein (SREHP) in the avirulent vaccine strain Salmonella typhi TY2 χ4297 (Δcya Δcrp Δasd): safety and immunogenicity in mice
|
Zhang, Tonghai |
|
1997 |
15 |
12-13 |
p. 1319-1322 4 p. |
artikel |
16 |
Hepatitis B component does not interfere with the immune response to diphtheria, tetanus and whole-cell Bordetella pertussis components of a quadrivalent (DTPw-HB) vaccine: a controlled trial in healthy infants
|
Diez-Delgado, Javier |
|
1997 |
15 |
12-13 |
p. 1418-1422 5 p. |
artikel |
17 |
Hepatitis B vaccine in hemodialysis patients with hepatitis C viral infection
|
Cheng, Chi-Hung |
|
1997 |
15 |
12-13 |
p. 1353-1357 5 p. |
artikel |
18 |
Immunization with a peptide derived from the G glycoprotein of bovine respiratory syncytial virus (BRSV) reduces the incidence of BRSV-associated pneumonia in the natural host
|
Bastien, Nathalie |
|
1997 |
15 |
12-13 |
p. 1385-1390 6 p. |
artikel |
19 |
Immunogenicity of an inactivated hepatitis A vaccine in Dutch United Nations troops
|
Hopperus Buma, A.P.C.C. |
|
1997 |
15 |
12-13 |
p. 1413-1417 5 p. |
artikel |
20 |
Induction of a cytotoxic T lymphocyte response by immunization with a malaria specific CTL peptide entrapped in biodegradable polymer microspheres
|
Men, Ying |
|
1997 |
15 |
12-13 |
p. 1405-1412 8 p. |
artikel |
21 |
Introducing ‘fence’ vaccines
|
Spier, R.E. |
|
1997 |
15 |
12-13 |
p. 1289-1290 2 p. |
artikel |
22 |
In vivo absorption of aluminium-containing vaccine adjuvants using 26Al
|
Flarend, Richard E. |
|
1997 |
15 |
12-13 |
p. 1314-1318 5 p. |
artikel |
23 |
Local tissue irritating effects and adjuvant activities of calcium phosphate and aluminium hydroxide with different physical properties
|
Goto, Norihisa |
|
1997 |
15 |
12-13 |
p. 1364-1371 8 p. |
artikel |
24 |
Manipulation of HIV-1 gp120-specific immune responses elicited via gene gun-based DNA immunization
|
Prayaga, Sudhirdas K. |
|
1997 |
15 |
12-13 |
p. 1349-1352 4 p. |
artikel |
25 |
Neisseria gonorrhoeae: vaginal clearance and its correlation with resistance to infection in subcutaneous chambers in orally immunized estradiol-primed mice
|
Arko, Robert J. |
|
1997 |
15 |
12-13 |
p. 1344-1348 5 p. |
artikel |
26 |
New immunogenic flavivirus peptide modified at C-terminus; dengue virus, yellow-fever virus, Japanese-encephalitis virus or hepatitis C virus recombinant vaccine expression in Spodoptera frugiperda insect cell culture using a baculovirus vector
|
|
|
1997 |
15 |
12-13 |
p. 1487- 1 p. |
artikel |
27 |
Perspectives on FIV vaccine development
|
Elyar, John S. |
|
1997 |
15 |
12-13 |
p. 1437-1444 8 p. |
artikel |
28 |
Prophylaxis of experimental HTLV-I infection in cynomolgus monkeys by passive immunization
|
Akari, Hirofumi |
|
1997 |
15 |
12-13 |
p. 1391-1395 5 p. |
artikel |
29 |
Raccoon poxvirus live recombinant feline panleukopenia virus VP2 and rabies virus glycoprotein bivalent vaccine
|
Hu, Liangbiao |
|
1997 |
15 |
12-13 |
p. 1466-1472 7 p. |
artikel |
30 |
Rapid identification of Newcastle disease virus vaccine strains LaSota and B-1 by restriction site analysis of their matrix gene
|
Wehmann, E. |
|
1997 |
15 |
12-13 |
p. 1430-1433 4 p. |
artikel |
31 |
Serum antibody responses of cattle vaccinated with partially purified native Pasteurella haemolytica leukotoxin
|
Confer, A.W. |
|
1997 |
15 |
12-13 |
p. 1423-1429 7 p. |
artikel |
32 |
Study of the adjuvant activity of new MDP derivatives and purified saponins and their influence on HIV-1 replication in vitro
|
Krivorutchenko, Yuri L. |
|
1997 |
15 |
12-13 |
p. 1479-1486 8 p. |
artikel |
33 |
Synthetic virus-like particles from new human papilloma virus type-6 and -11 constructs — virus-like particle construction for virus infection characterization and vaccine generation; plasmid pVL1393 expression in Spodoptera frugiperda Sf9 insect culture
|
|
|
1997 |
15 |
12-13 |
p. 1487- 1 p. |
artikel |
34 |
Ten-year follow-up study of neonatal hepatitis B immunization: are booster injections indicated?
|
Resti, Massimo |
|
1997 |
15 |
12-13 |
p. 1338-1340 3 p. |
artikel |
35 |
The organization of human leucocyte antigen class I epitopes in HIV genome products: implications for HIV evolution and vaccine design
|
Zhang, Chao |
|
1997 |
15 |
12-13 |
p. 1291-1302 12 p. |
artikel |
36 |
The use of sequence analysis of a feline calicivirus (FCV) hypervariable region in the epidemiological investigation of FCV related disease and vaccine failures
|
Radford, A.D. |
|
1997 |
15 |
12-13 |
p. 1451-1458 8 p. |
artikel |
37 |
Validation of cold chain procedures suitable for distribution of vaccines by public health programs in the USA
|
Kendal, Alan P. |
|
1997 |
15 |
12-13 |
p. 1459-1465 7 p. |
artikel |